Drug interactions
Cenobamate + Linagliptin-metformin
Severity: Minor
Cenobamate and Linagliptin-metformin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Cenobamate can induce CYP3A4 and may lower linagliptin exposure, possibly weakening glucose control slightly. Metformin is not affected through this pathway.
What this interaction means in plain words
Cenobamate and Linagliptin-metformin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Cenobamate belongs to Central Nervous System; Linagliptin-metformin belongs to Endocrine.
Why it happens
CYP3A4 induction by cenobamate increases linagliptin clearance.
What to do
Monitor glucose and HbA1c after starting or stopping cenobamate. Intensify therapy if control worsens.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Cenobamate and Linagliptin-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Linagliptin-metformin
Other interactions of Cenobamate
Frequently asked questions
Can I take Cenobamate with Linagliptin-metformin?
MediHelp rates the interaction as minor. Cenobamate and Linagliptin-metformin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Cenobamate can induce CYP3A4 and may lower linagliptin exposure, possibly weakening glucose control slightly. Metformin is not affected through this pathway.
How serious is the interaction between Cenobamate and Linagliptin-metformin?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose and HbA1c after starting or stopping cenobamate. Intensify therapy if control worsens.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
